QUEBEC CITY,
March 12, 2014 /PRNewswire/ - Aeterna
Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will
announce its fourth quarter and full-year 2013 financial and
operating results after market close on Thursday, March 20, 2014. The Company will host a
conference call to discuss these results on Friday, March 21, 2014, at 8:30 a.m., Eastern Time.
Participants may access the live webcast via the
Company's website at www.aezsinc.com in the "Newsroom" section, or
by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company engaged
in developing novel treatments in oncology and endocrinology. The
Company's pipeline encompasses compounds at various stages of
development. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.